Prevalance of extended spectrum beta-lactamases among escherichia coli and klebsiella pneumoniae in isolates from Mulago National Referral Hospital.

dc.contributor.author Nabatanzi, Ritah
dc.date.accessioned 2022-05-24T09:39:15Z
dc.date.available 2022-05-24T09:39:15Z
dc.date.issued 2022-03
dc.description A dissertation submitted to Makerere University School of Biomedical Sciences in partial fulfillment of the requirements for the award of the Bachelors Degree of Sciences in Biomedical Sciences. en_US
dc.description.abstract Escherichia coli (E.coli) and Klebsiella pneumoniae are gram-negative bacteria that are members of the enterobacteriaceae family of bacteria. Antimicrobial resistance is one of the most serious risks to global public health. Most antibiotics are losing their effectiveness against Gram negative bacteria (GNB) and this is due to presence of extended spectrum beta lactamase (ESBLs). The major goal of this study was to determine the prevalence of TEM and CTX-MU genes in E. coli and Klebsiella pneumoniae isolates from Mulago National Referral Hospital. The isolates were obtained from storage, thawed, sub-cultured on Mac Conkey agar and identified using biochemical identification tests. Susceptibility testing of isolates to antibiotics was performed using disc diffusion method. DNA was extracted by boiling lysis and TEM and CTX-MU genes were determined by polymerase chain reaction (PCR). Antimicrobial resistance patterns of isolates were as follows; 30/30 (100%) of the isolates were resistant to Ampicillin, 23/30 (76.7%) of isolates were resistant to Cefotaxime, Ceftriaxone and Ceftazidime, 26/30 (86.7%) of the isolates were resistant to Cefuroxime, 10/30 (33.3%) of isolates were resistant to Meropenem, 13/30 (43.3%) of isolates were resistant to Imipenem. Percentage prevalence of TEM and CTX-MU genes were as follows: 7/9 (77.8%) of the isolates contained CTX-MU, 4/9 (44.4%) of the isolates contained TEM In conclusion, ESBL producing organisms should be promptly identified for appropriate antibiotic prescription. The ministry of health should take into consideration prescribing practices and improve them through the use of diagnostic tests, improved documentation of symptoms so as to reduce resistant bacteria through inappropriate prescription. en_US
dc.identifier.citation Nabatanzi, R. (2022). Prevalance of extended spectrum beta-lactamases among escherichia coli and klebsiella pneumoniae in isolates from Mulago National Referral Hospital (Unpublished undergraduate dissertation). Makerere University, Kampala, Uganda. en_US
dc.identifier.uri http://hdl.handle.net/20.500.12281/12924
dc.language.iso en en_US
dc.publisher Makerere University en_US
dc.subject Carbapenems en_US
dc.subject Prevalance of extended spectrum Beta-lactamases among Escherichia Coli and Klebsiell Pneumoniae en_US
dc.subject Isolates from Mulago National Referral Hospital. en_US
dc.title Prevalance of extended spectrum beta-lactamases among escherichia coli and klebsiella pneumoniae in isolates from Mulago National Referral Hospital. en_US
dc.type Thesis en_US
Files